The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Case Report
Obesity and diabetes, the pandemic of our time: the difficult to manage complication of diabetes, diabetic foot
Overweight and obesity are major problems worldwide, affecting more than half of the adult population. With wrong eating habits, the rise of fast-food culture and sedentary lifestyles, obesity continues to spread almost all over the world. In addition to the many physical problems obesity causes, it also significantly affects mental health. One of the most feared conditions caused by obesity is type 2 diabetes, a systemic disease that negatively affects every part of the body. In addition to the many problems it causes, diabetes causes foot problems in one out of every 6-7 patients throughout their lives, some of which may lead to limb loss and even death. The average life expectancy of patients with diabetic foot is significantly shortened. Treatment of these patients is also very costly. In this case report, we tried to explain the relationship between obesity and diabetes and diabetic foot problems that can lead to serious financial and moral losses.

1. Karslıoğlu DH. Obezite, tip 2 diyabet ve beslenme. Klin Tıp Bil. 2019; 7(3):36-43.
2. WHO Consultation on Obesity (1999: Geneva, Switzerland) & World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-253.
3. Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804-814.
4. Bailes BK. Diabetes mellitus and its chronic complications. AORN J. 2002;76(2):266-286.
5. Erdogan Erden E, Yazici ZG, Kilic Tatlici C, Aydin S, Kilic FS. Pharmacological approaches in obesity treatment. Osmangazi J Med. 2023;45(1):142-150 doi: 10.20515/otd.1093390
6. DeFronzo RA, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015; 1:15019.
7. Delgado MM. Clinical case: complicated diabetic foot ulcer. Revista Espanola de Sanidad Penitenciaria. 2018;20(3):121.
8. Klein S, Gastaldelli A, Yki-Järvinen H, Scherer PE. Why does obesity cause diabetes? Cell Metabolism. 2022;34(1):11-20.
9. Armstrong DG, Tan TW, Boulton AJ, Bus SA. Diabetic foot ulcers: a review. JAMA. 2023;330(1): 62-75.
10. McDermott K, Fang M, Boulton AJ, Selvin E, Hicks CW. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care. 2023;46(1):209-221.
11. Rosskopf AB, Loupatatzis C, Pfirrmann CW, Böni T, Berli MC. The Charcot foot: a pictorial review. Insights Imaging. 2019;10(1):77.
12. Good to know: diabetes symptoms and tests. Clin Diabetes. 2020;38(1): 108. doi: 10.2337/cd20-pe01
13. Thomas MC, Brownlee M, Susztak K, et al. Diabetic kidney disease. Nat Rev Dis Primers. 2015;1(1):15018.
14. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009; 374(9702):1677-1686.
Volume 2, Issue 2, 2024
Page : 36-38